stiripentol has been researched along with Intellectual Disability in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Canafoglia, L; Castellotti, B; D'Arrigo, S; DiFrancesco, JC; Freri, E; Gellera, C; Granata, T; Magri, S; Messina, G; Ragona, F; Solazzi, R; Vannicola, C | 1 |
| Specchio, N; Trivisano, M; Vigevano, F | 1 |
| Barsi, P; Claes, L; De Jonghe, P; Fogarasi, A; Hegyi, M; Herczegfalvi, A; Karcagi, V; Neuwirth, M; Pálmafy, B; Paraicz, E; Siegler, Z; Tegzes, A | 1 |
3 other study(ies) available for stiripentol and Intellectual Disability
| Article | Year |
|---|---|
Severe epilepsy in CNTNAP2-related Pitt-Hopkins-like syndrome successfully treated with stiripentol.
Topics: Dioxolanes; Epilepsy; Humans; Hyperventilation; Intellectual Disability; Membrane Proteins; Nerve Tissue Proteins | 2021 |
Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy.
Topics: Age of Onset; Anticonvulsants; Autistic Disorder; Benzodiazepines; Cadherins; Child; Clobazam; Cognition Disorders; Dioxolanes; Drug Resistant Epilepsy; Drug Therapy, Combination; Epilepsies, Myoclonic; Epilepsy; Female; Fever; Humans; Intellectual Disability; Protocadherins; Syndrome; Treatment Outcome; Valproic Acid | 2015 |
[Clinical and genetic diagnosis of Dravet syndrome: report of 20 cases].
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Dioxolanes; DNA Mutational Analysis; Electroencephalography; Epilepsies, Myoclonic; Epilepsy, Absence; Epilepsy, Complex Partial; Female; Humans; Hungary; Infant; Intellectual Disability; Magnetic Resonance Imaging; Male; Mutation; Myoclonic Epilepsy, Juvenile; NAV1.1 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Psychomotor Disorders; Seizures, Febrile; Sodium Channels | 2008 |